@article{rosenthal:hal-01740817,
  TITLE = {{Efficacy, safety and patient-reported outcomes of ledipasvir/sofosbuvir in NS3/4A protease inhibitor-experienced individuals with hepatitis C virus genotype 1 and HIV coinfection with and without cirrhosis (ANRS HC31 SOFTRIH study)}},
  AUTHOR = {Rosenthal, E. and Fougerou-Leurent, C and Renault, A. and Carrieri, Mp. and Marcellin, F. and Garraffo, R and Teicher, E. and Aumaitre, H and Lacombe, K. and Bailly, F. and Billaud, E. and Chevaliez, S. and Dominguez, S and Valantin, Ma. and Reynes, Jacques and Naqvi, A. and Cotte, L and Metivier, S and Leroy, V. and Dupon, M. and Allegre, T. and de Truchis, P. and Jeantils, V. and Chas, J and Salmon-Ceron, D and Morlat, P and Neau, D and Perr{\'e}, P and Piroth, L and Pol, S. and Bourli{\`e}re, M. and Pageaux, Georges Philippe and Alric, Laurent and Zucman, D. and Girard, Pm. and Poizot-Martin, I and Yazdanpanah, Y and Raffi, F. and Pabic, E and Tual, C. and Pailh{\'e}, A and Amri, I and Bellissant, E. and Molina, J. M.},
  URL = {https://hal.umontpellier.fr/hal-01740817},
  JOURNAL = {{HIV Medicine}},
  PUBLISHER = {{Wiley}},
  VOLUME = {19},
  NUMBER = {3},
  PAGES = {227-237},
  YEAR = {2018},
  MONTH = Mar,
  DOI = {10.1111/hiv.12571},
  KEYWORDS = {hepatitis C virus ; treatment ; HIV ; coinfection ; ledipasvir ; sofosbuvir},
  PDF = {https://hal.umontpellier.fr/hal-01740817v1/file/Rosenthal_Efficacy%2C%20safety%20and%20patient-reported.pdf},
  HAL_ID = {hal-01740817},
  HAL_VERSION = {v1},
}